The Boehringer Ingelheim Veterinary Scholars Program was established more than 30 years ago to introduce first- and second-year veterinary medical students to biomedical research and meet at the annual National Veterinary Scholars Symposium.
Respiratory disease research continues to be the focus for the 11th year of the awards from Boehringer Ingelheim.
Boehringer Ingelheim Animal Health USA Inc. announced the creation of Pawru, Inc. as a separate company within the Boehringer Ingelheim Animal Health business.
Boehringer Ingelheim Animal Health, a leading provider of medicine for pets, horses and livestock, announced today the appointment of Randolph Legg as its U.S. president.
The Aservo EquiHaler (ciclesonide inhalation spray), an industry first in equine medicine, addresses an unmet need for horses with severe equine asthma.
Boehringer Ingelheim will present five separate $15,000 awards focused on two specific disease topics.
A donation to The Foundation for the Horse and a video honor dedication and care provided by equine veterinarians.
Updated, centralized resources include online neurological exam, interactive EPM diagnostic tool
Providing a “gut check” can help you better diagnose, treat and prevent equine gastric disease.
Boehringer Ingelheim Animal Health (BI) has put together a toolkit and video to help horse owners understand diagnosing and treating gastric ulcers.
Boehringer Ingelheim is accepting proposals for the 2018 Advancement in Equine Research Awards for Equine Respiratory Disease Research.
Boehringer Ingelheim (BI) has selected three research proposals to fund as part of its 2017 Advancement in Equine Research Award program. Since 2011 BI has given more than $470,000 to advancing the knowledge of equine infectious disease.
Today marks the 10th time that Boehringer Ingelheim has received a perfect score on the Corporate Equality Index (CEI) and has been designated as a 2018 Best Place to Work for LGBTQ Equality.
Boehringer Ingelheim today announced it has been named to Science magazine’s annual list of “top employers” within the pharmaceutical and biotechnology industry for the 13th consecutive year. Boehringer Ingelheim was one of only 20 companies recognized.
As part of a three-year commitment, Boehringer Ingelheim has become FEI Equine Health Partner and FEI Campus Partner.
Boehringer Ingelheim announced today that for the sixth consecutive year it has been named to Working Mother magazine’s annual 100 Best Companies list.
Travel can significantly increase the risk of a horse contracting an infectious disease.
As the days get shorter and opportunities for equine activities dwindle, the immunity provided by some vaccinations administered earlier in the year may also be diminishing.
Boehringer Ingelheim once again invites public and private researchers studying equine infectious diseases to submit proposals for the 2017 Equine Research Awards.
Veterinary technicians and assistants play a critical role in horse health. To recognize their contributions, Boehringer Ingelheim (BI), EquiManagement magazine, and the American Association of Equine Veterinary Technicians and Assistants (AAEVT) are accepting nominations for the Champions of the Cause Award for the third year. The nomination period will run from April 17, 2017 to July 14, 2017.